Persistent bacterial infections and primary immune disorders

Current Opinion in Microbiology

Volumn 10, Issue 1, 2007, Pages 70-75

  Freeman, Alexandra F ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON;

BACTEREMIA; ENVIRONMENT; GENETIC VARIABILITY; HELICOBACTER; HELICOBACTER INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY IMMUNE RESPONSE; REVIEW; SALMONELLA; SALMONELLOSIS; SKIN INFECTION;

BACTERIAL INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HUMANS; IMMUNE SYSTEM DISEASES; MYCOBACTERIUM INFECTIONS; SALMONELLA INFECTIONS;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CORYNEBACTERINEAE; FLEXISPIRA; HELICOBACTER; SALMONELLA;

EID: 33846811454     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2006.11.005     Document Type: Review

References (37)

1. Rengarajan J., Bloom B.R., and Rubin E.J. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 102 (2005) 8327-8332. A genome-wide screen identifying M. tuberculosis genes involved in survival within the macrophage.
2. Munoz-Elias E.J., and McKinney J.D. M. tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11 (2005) 638-644
3. Lazarevic V., Nolt D., and Flynn J.L. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune response. J Immunol 175 (2005) 1107-1117
4. Monack D.M., Mueller A., and Falkow S. Persistent bacterial infections: the interface of the pathogen and the immune system. Nat Rev Microbiol 2 (2004) 747-765
5. Feng C.G., Jankovic D., Kullberg M., Cheever A., Scanga C.A., Hieny S., Caspar P., Yap G.S., and Sher A. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 174 (2005) 4185-4192
6. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basaraba R.J., Kipnis A., Orme I.M., and Cooper A.M. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169 (2002) 6343-6351
7. Brodsky I.E., Ghori N., Falkow S., and Monack D. Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol 55 (2005) 954-972
8. Lawley T.D., Chan K., Thompson L.J., Kim C.C., Govoni G.R., and Monack D.M. Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse. PLoS Pathog 2 (2006) 87-100. A genome screen identifying genes contributing to long-term persistence of Salmonella infection.
9. Sashinami H., Yamamoto T., and Nakane A. The cytokine balance in the maintenance off a persistent infection with Salmonella enterica serovar Typhimurium in mice. Cytokine 33 (2006) 212-218
10. Vazquez-Torres A., Xu Y., Jones-Carson J., Holden D.W., Lucia S.M., Dinauer M.C., Mastroeni P., and Fang F.C. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287 (2000) 1655-1658
11. Monack D.M., Bouley D.M., and Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFN-gamma neutralization. J Exp Med 199 (2004) 231-241
12. Doffinger R., Patel S., and Kumararatne D.S. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr Opin Rheumatol 17 (2005) 440-446. A review of immunodeficiencies associated with mycobacterial and Salmonella infections.
13. Dorman S.E., and Holland S.M. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 101 (1998) 2364-2369
14. Dorman S.E., Picard C., Lammas D., Heyne K., van Dissel J.T., Baretto R., Rosenzweig S.D., Newport M., Levin M., Roesler J., et al. Clinical features of dominant and recessive interferon-gamma receptor 1 deficiencies. Lancet 364 (2004) 2113-2121
15. Rosenzweig S.D., Dorman S.E., Uzel G., Shaw S., Scurlock A., Brown M.R., Buckley R.H., and Holland S.M. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 173 (2004) 4000-4008
16. Tsolia M.N., Chapgier A., Taprantzi P., Servitzoglou M., Tassios I., Spyridis N., Papageorgiou F., Filipe-Santos O., Casanova J.-L., and Spyridis P. Disseminated nontuberculous mycobacterial infection in a child with interferon-gamma receptor 1 deficiency. Eur J Pediatr 165 (2006) 458-461
17. MacLennan C., Fieschi S., Lammas D.A., Picard C., Dorman S.E., Sanal O., MacLennan J.M., Holland S.M., Ottenhoff T.H., Casanova J.L., et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 190 (2004) 1755-1757
18. Zerbe C.S., and Holland S.M. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 41 (2005) e38-e41
19. Filipe-Santos O., Bustamante J., Haverkamp M.H., Vinolo E., Ku C.-L., Puel A., Frucht D.M., Christel K., von Bernuth H., Jouanguy E., et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203 (2006) 1745-1759. A key paper describing the mechanism behind NEMO mutations resulting in immune deficiency.
20. Durandy A., Peron S., and Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol 18 (2006) 369-376
21. Temmerman S.T., Ma C.A., Borges L., Kubin M., Liu S., Derry J.M.J., and Jain A. Impaired dendritic cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination. Blood 108 (2006) 2324-2331
22. Orange J.S., Jain A., Ballas J.K., Schneider L.C., Geha R.S., and Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kB essential modulator mutation. Basic and Clinical Immunology 113 (2004) 725-733
23. Doffinger R., Helbert M.R., Barcenas-Morales G., Yang K., Dupuis S., Ceron-Gutierrez L., Espitia-Pinzon C., Barnes N., Bothamley G., Casanova J.L., et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38 (2004) e10-e14
24. Hoflich C., Sabat R., Rosseau S., Temmesfeld B., Slevogt H., Docke W.D., Grutz G., Meisel C., Halle E., Gobel U.B., et al. Naturally occurring anti-IFN gamma autoantibody and severe infections with Mycobacterium chelonae and Burkholderia cocovenenans. Blood 103 (2004) 673-675
25. Kampmann B., Hemingway C., Stephens A., Davidson R., Goodsall, Anderson S., Nicol M., Schölvinck E., Relman D., Waddell S., et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 115 (2005) 2480-2488
26. Patel S.Y., Ding L., Brown M.R., Lantz L., Gay T., Cohen S., Martyak L.A., Kubak B., and Holland S.M. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 175 (2005) 4769-4776. A description of six patients with high-titer autoantibodies to IFN-γ including the clinical, laboratory and immunologic features.
27. Tran D.Q. Susceptibility to mycobacterial infections due to interferon-gamma and interleukin-12 pathway defects. Allergy Asthma Proc 26 (2005) 418-421
28. Cuccherini B., Chua K., Gill V., Weir S., Wray B., Stewart D., Nelson D., Fuss I., and Strober W. Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species. Clin Immunol 97 (2000) 121-129
29. Gerrard J., Alfredson D., and Smith I. Recurrent bacteremia and multifocal lower limb celluitis due to Helicobacter-like organisms in a patient with X-linked hypogammaglobulinemia. Clin Infect Dis 33 (2001) e116-e118
30. Tokuda K., Nishi J., Miyanohara H., Sarantuya J., Iwashita M., Kamenosono A., Hizukuri K., Wakimoto N., and Yoshinaga M. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J 23 (2004) 577-579
31. Cooke C.L., Huff J.L., and Solnick J.V. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. FEMS Immunol Med Microbiol 45 (2005) 11-23. An excellent review of the host and pathogen features of H. pylori.
32. Khamri W., Moran A.P., Worku M.L., Karim Q.N., Walker M.M., Annuk H., Ferris J.A., Appelmelk B.J., Eggleton P., Reid K.B., and Thursz M.R. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun 73 (2005) 7677-7686
33. Gerwitz A.T., Yu Y., Krishna U.S., Israel D.A., Lyons S.L., and Peek Jr. R. Helicobacter pylori flagellin evades Toll-like receptor 5-mediated innate immunity. J Infect Dis 189 (2004) 1914-1920
34. Gobert A.P., McGee D.J., Akhtar M., Mendz G.L., Newton J.C., Cheng Y., Mobley H.L.T., and Wilson K.T. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 98 (2001) 13844-13849
35. Lundgren A., Stromberg E., Sjoling A., Lindholm C., Enarsson K., Edebo A., Johnsson E., Suri-Payer E., Larsson P., Rudin A., et al. Mucosal FOXP3-expressing CD4+CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73 (2005) 523-531
36. Sundrud M.S., Torres V.J., Unutmaz D., and Cover T.L. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 18 (2004) 7727-7732
37. Akhiani A.A., Stensson A., Schon K., and Lycke N.Y. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 174 (2005) 8144-8153